Is a postdoctoral researcher from Prof. Diego Muñoz-Torrero’s group with a Juan de la Cierva research fellowship, developing compounds against neurodegenerative diseases and neuropathic pain. She obtained her PhD in Drug Research and Development in 2021 at CiQUS under the supervision of Prof. Eddy Sotelo, focused on multicomponent reactions to synthesize compounds targeting GPCRs. Subsequently, she worked in the biotech start-up Oncostellae developing small-molecule drug

Is a postdoctoral researcher in Prof. Diego Muñoz-Torrero’s group. After completing her PhD studies with a FPU scholarship in the same group, she continues her research focusing on innovative treatments for neurodegenerative diseases. She previously worked at Trinity College Dublin as a pregraduate Erasmus+ student and conducted research stays at QPS Austria Neuropharmacology and Goethe University Frankfurt during her PhD. She has experience in chemical synthesis and in vitro assays and has been entrepreneur scientist in two valorization projects.

Is a 4th year PhD student at the group of Prof. Diego Muñoz-Torrero, for which he received a scholarship granted by the Philippine – Department of Science and Technology (DOST). He has high affinity toward designing drug candidates against neurodegenerative diseases. He was also a project manager for Philippine Health Research Council.

Is a 4th year PhD student at the group of Diego Muñoz-Torrero holding a FPU scholarship. She has experience synthesising novel compounds that hit multiple targets involved in Alzheimer’s disease, and she also performs biological in vitro assays, as well as computational studies in the group of her co-director Dr. Carles Galdeano. She has also performed a predoctoral stay in the group of Prof. Bruce Hammock at the University of California Davis.

Holds a Chemistry degree from the Autonomous University of Madrid and a master’s degree in Drug Discovery. He worked as a synthetic chemist at the Spanish National Cancer Research Center (CNIO), gaining experience in early-stage drug discovery. In September 2022, he began his Ph.D. under the supervision of Dr. Diego Muñoz-Torrero and Dr. Santiago Vázquez. His research focuses on designing, synthesizing, and evaluating new drugs with innovative mechanisms to treat neurodegenerative diseases and neuropathic pain.

Is a 1st-year PhD student in Medicinal Chemistry at the University of Barcelona, specializing in the design and synthesis of anti-Alzheimer compounds. He gained international experience during his Erasmus+ exchange at the Università di Pavia and has been part of Dr. Diego Muñoz-Torrero’s research group since 2022, focusing on drug discovery for neurodegenerative diseases.

Is a first year PhD student holding a scholarship form the Chinese Scholarships Council (CSC). He obtained a Master’s degree in Pharmaceutical Engineering from Northwest University, China in 2023. He has experience in chemical synthesis. Now his research focuses on designing and synthesizing new compounds for treating Alzheimer’s disease.

Is currently a 1st-year PhD student in Prof. Diego Muñoz-Torrero’s group. She obtained her master’s degree in drug discovery from the University of Edinburgh, and her bachelor’s degree in medicinal chemistry from China Pharmaceutical University respectively. With experience of both organic synthesis and biological assay, her research focuses on the antimalarial agents and chemical probes for the identification of drug targets.

Is an undergraduate student in her fifth year of the Pharmacy Degree at the University of Barcelona. She has been working in the group of Dr. Diego Muñoz-Torrero since July 2023, in a project whose goal is to synthesize possible new anti-Alzheimer’s compounds.